Campus Reacts to Strobel

BOZEMAN, MONT.—The deliberate violation by a Montana State University scientist of EPA regulations on the release of genetically engineered organisms has evoked sharply different reactions from scientists and top administrators on campus. While colleagues criticize him in harsh terms, university officials say they welcome the increased attention to the impact of federal regulations on science. At issue is plant pathology professor Gary Strobel’s June release into the wild of a ge

Written byWilliam Brock
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BOZEMAN, MONT.—The deliberate violation by a Montana State University scientist of EPA regulations on the release of genetically engineered organisms has evoked sharply different reactions from scientists and top administrators on campus. While colleagues criticize him in harsh terms, university officials say they welcome the increased attention to the impact of federal regulations on science.

At issue is plant pathology professor Gary Strobel’s June release into the wild of a genetically altered strain of the bacterium Pseudomonas syringae. Strobel admits he did not wait for EPA approval to release the bacteria into a group of elm trees and that he willfully violated the federal regulations.

MSU President William Tietz, speaking before the university had completed its review of the case, said he is not upset about the notoriety Strobel has brought to the university. “We have a major controversy and a major set of circum stances coming together at MSU ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies